|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
50.700 +0.050 (+0.099%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 7,085,471 | 35.905% | 5,213,538 | 3,192,279 | 2,803,309 | 2,299,534 | |
| Cost of Sales | (4,300,027) | 45.006% | (2,965,420) | (1,688,946) | (1,511,409) | (1,318,199) | |
| Gross Profit | 2,785,444 | 23.901% | 2,248,118 | 1,503,333 | 1,291,900 | 981,335 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (24,575) | 0.610% | (24,426) | 10,075 | (21,186) | (53,105) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (3,567) | -- | -- | |
| Share of Results of Asso. & JCEs | 39,763 | 177.133% | 14,348 | (3,508) | (9,768) | 9,598 | |
| Profit / (Loss) before Taxation | 2,594,912 | -29.668% | 3,689,502 | 2,220,262 | 1,088,772 | 762,902 | |
| Taxation | (313,652) | 7.098% | (292,864) | (189,707) | (113,839) | (107,653) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (265,174) | -48.763% | (517,539) | (279,227) | (133,686) | (78,363) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,016,086 | -29.975% | 2,879,099 | 1,751,328 | 841,247 | 576,886 | |
| Net Finance Costs / (Income) | (145,249) | -37.965% | (234,139) | (63,317) | 15,409 | 10,019 | |
| Depreciation & Amortisation | 284,844 | 44.766% | 196,762 | 150,256 | 104,202 | 61,270 | |
| Directors' Emoluments | -- | -- | 3,487 | 3,395 | 2,801 | 2,887 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 233.000 | -- | 332.000 | 220.000 | 113.000 | 77.000 |
| DPS (cts) | 55.000 | -- | 50.000 | 30.000 | -- | -- |
| Dividend Payout Ratio (%) | 23.605% | -- | 15.060% | 13.636% | -- | -- |
| Cash flow per share ($) | -- | -- | 1.343 | 1.125 | 0.725 | 0.679 |
| NBV per share ($) | 22.499 | -- | 20.844 | 18.514 | -- | -- |
| Remarks: | Real time quote last updated: 09/06/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,016,086 |
| %Change | -29.975% |
| EPS / (LPS) | RMB 2.330 |
| NBV Per Share (¥) | RMB 22.499 |